Ying Huang
Stock Analyst at B of A Securities
(1.58)
# 2,382
Out of 4,479 analysts
21
Total ratings
56%
Success rate
10.1%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $350 → $400 | $473.78 | -15.57% | 3 | Jul 21, 2023 | |
| RDUS Radius Health | Maintains: Buy | n/a | $14.67 | - | 1 | Jul 25, 2018 | |
| RGNX REGENXBIO | Downgrades: Neutral | n/a | $10.75 | - | 3 | Jul 23, 2018 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | n/a | $2.34 | - | 2 | May 2, 2018 | |
| CTMX CytomX Therapeutics | Maintains: Buy | n/a | $1.32 | - | 2 | Mar 8, 2018 | |
| BLUE bluebird bio | Maintains: Neutral | n/a | $0.92 | - | 1 | Feb 22, 2018 | |
| GILD Gilead Sciences | Maintains: Neutral | n/a | $68.40 | - | 2 | Feb 7, 2018 | |
| PBYI Puma Biotechnology | Maintains: Buy | n/a | $3.10 | - | 2 | Jan 24, 2018 | |
| IRWD Ironwood Pharmaceuticals | Downgrades: Underperform | n/a | $6.22 | - | 1 | Jan 5, 2018 | |
| BIIB Biogen | Maintains: Buy | n/a | $228.82 | - | 1 | Oct 18, 2017 | |
| BOLD Boundless Bio | Maintains: Buy | n/a | $4.30 | - | 1 | Sep 22, 2017 | |
| ALRN Aileron Therapeutics | Initiates: Buy | n/a | $2.76 | - | 1 | Jul 24, 2017 | |
| AMGN Amgen | Upgrades: Buy | n/a | $310.77 | - | 1 | Feb 1, 2017 |
Vertex Pharmaceuticals
Jul 21, 2023
Maintains: Buy
Price Target: $350 → $400
Current: $473.78
Upside: -15.57%
Radius Health
Jul 25, 2018
Maintains: Buy
Price Target: n/a
Current: $14.67
Upside: -
REGENXBIO
Jul 23, 2018
Downgrades: Neutral
Price Target: n/a
Current: $10.75
Upside: -
Esperion Therapeutics
May 2, 2018
Downgrades: Underperform
Price Target: n/a
Current: $2.34
Upside: -
CytomX Therapeutics
Mar 8, 2018
Maintains: Buy
Price Target: n/a
Current: $1.32
Upside: -
bluebird bio
Feb 22, 2018
Maintains: Neutral
Price Target: n/a
Current: $0.92
Upside: -
Gilead Sciences
Feb 7, 2018
Maintains: Neutral
Price Target: n/a
Current: $68.40
Upside: -
Puma Biotechnology
Jan 24, 2018
Maintains: Buy
Price Target: n/a
Current: $3.10
Upside: -
Ironwood Pharmaceuticals
Jan 5, 2018
Downgrades: Underperform
Price Target: n/a
Current: $6.22
Upside: -
Biogen
Oct 18, 2017
Maintains: Buy
Price Target: n/a
Current: $228.82
Upside: -
Boundless Bio
Sep 22, 2017
Maintains: Buy
Price Target: n/a
Current: $4.30
Upside: -
Aileron Therapeutics
Jul 24, 2017
Initiates: Buy
Price Target: n/a
Current: $2.76
Upside: -
Amgen
Feb 1, 2017
Upgrades: Buy
Price Target: n/a
Current: $310.77
Upside: -